Use of analgesics in France, following dextropropoxyphene withdrawal

BACKGROUND: In 2009, the European Medicines Agency recommended withdrawal of dextropropoxyphene (DXP); in March 2011 it was withdrawn from the market in France. Up until that time the combination dextropropoxyphene-paracetamol (DXP/PC) was widely used for analgesia. At withdrawal, French regulators...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Ganse, E., Belhassen, M., Ginoux, M., Chrétien, E., Cornu, C., Ecoffey, C., Aubrun, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880096/
https://www.ncbi.nlm.nih.gov/pubmed/29609613
http://dx.doi.org/10.1186/s12913-018-3058-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880096/
https://www.ncbi.nlm.nih.gov/pubmed/29609613
http://dx.doi.org/10.1186/s12913-018-3058-1

Ejemplares similares